TABLE 1.
Characteristics of control women and patients with PCOS.
| Characteristic | N-PCOS (n = 6) | O-PCOS (n = 6) | N-CON (n = 6) | O-CON (n = 6) | p-value a | p-value b | p-value c | p-value d |
|---|---|---|---|---|---|---|---|---|
| Age (y) | 30.0 (25.0–36.0) | 29.7 (28.0–30.0) | 30.5 (28.0–33.0) | 30.7 (24.0–36.0) | 0.807 | 0.695 | 0.860 | 0.950 |
| BMI (kg/m2) | 21.3 (19.5–23.9) | 27.3 (26.4–29.6) | 21.0 (18.9–24.2) | 26.6 (25.7–27.7) | 0.756 | 0.236 | 0.000 | 0.000 |
| FSH (IU/L) | 6.9 (3.6–10.8) | 5.7 (4.3–8.9) | 4.0 (2.0–7.1) | 4.1 (2.1–7.2) | 0.057 | 0.204 | 0.380 | 0.945 |
| LH (IU/L) | 11.3 (3.2–18.8) | 4.7 (2.4–6.3) | 3.0 (1.7–4.7) | 2.7 (1.3–4.3) | 0.005 | 0.023 | 0.018 | 0.681 |
| LH/FSH ratio | 1.98 (0.43–4.52) | 0.85 (0.53–1.30) | 0.85 (0.35–1.35) | 0.70 (0.50–1.02) | 0.103 | 0.314 | 0.103 | 0.354 |
| Total T (ng/ml) | 0.5 (0.3–0.8) | 0.5 (0.1–1.1) | 0.3 (0.1–0.7) | 0.2 (0.1–0.4) | 0.087 | 0.237 | 0.586 | 0.317 |
| TSH (μIU/ml) | 2.2 (1.3–3.2) | 2.5 (1.2–3.9) | 1.8 (1.5–2.3) | 2.6 (1.3–3.7) | 0.250 | 0.916 | 0.608 | 0.148 |
| Fasting glucose (mmol/L) | 5.3 (5.0–6.1) | 5.5 (5.1–6.2) | — | — | — | — | 0.555 | — |
| Fasting insulin (μU/mL) | 10.7 (5.0–18.0) | 13.5 (9.6–21.9) | — | — | — | — | 0.285 | — |
| AMH (ng/ml) | 3.6 (2.6–5.9) | 5.1 (3.4–9.5) | 4.0 (1.5–6.6) | 3.6 (2.6–5.9) | 0.385 | 0.224 | 0.148 c | 0.703 |
Note: BMI: body mass index; FSH: follicle-stimulating hormone; LH: luteinizing hormone; T: testosterone; TSH: thyroid-stimulating hormone; AMH: anti-Mullerian hormone.
a
N-PCOS vs N-CON.
b
O-PCOS vs O-CON.
c
N-PCOS vs O-PCOS.
d
N-CON vs O-CON.